S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   426.17 (+0.08%)
AAPL   168.13 (+0.08%)
MSFT   408.42 (-0.83%)
META   507.55 (+2.71%)
GOOGL   156.04 (+0.37%)
AMZN   181.17 (-0.06%)
TSLA   151.16 (-2.76%)
NVDA   846.91 (+0.78%)
AMD   154.87 (+0.55%)
NIO   4.02 (+2.81%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   117.10 (+0.66%)
GE   157.73 (+1.32%)
CGC   6.95 (+7.09%)
DIS   113.49 (+0.49%)
AMC   2.81 (-5.70%)
PFE   25.40 (-0.08%)
PYPL   63.11 (-0.24%)
XOM   118.84 (+0.18%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   426.17 (+0.08%)
AAPL   168.13 (+0.08%)
MSFT   408.42 (-0.83%)
META   507.55 (+2.71%)
GOOGL   156.04 (+0.37%)
AMZN   181.17 (-0.06%)
TSLA   151.16 (-2.76%)
NVDA   846.91 (+0.78%)
AMD   154.87 (+0.55%)
NIO   4.02 (+2.81%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   117.10 (+0.66%)
GE   157.73 (+1.32%)
CGC   6.95 (+7.09%)
DIS   113.49 (+0.49%)
AMC   2.81 (-5.70%)
PFE   25.40 (-0.08%)
PYPL   63.11 (-0.24%)
XOM   118.84 (+0.18%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   426.17 (+0.08%)
AAPL   168.13 (+0.08%)
MSFT   408.42 (-0.83%)
META   507.55 (+2.71%)
GOOGL   156.04 (+0.37%)
AMZN   181.17 (-0.06%)
TSLA   151.16 (-2.76%)
NVDA   846.91 (+0.78%)
AMD   154.87 (+0.55%)
NIO   4.02 (+2.81%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   117.10 (+0.66%)
GE   157.73 (+1.32%)
CGC   6.95 (+7.09%)
DIS   113.49 (+0.49%)
AMC   2.81 (-5.70%)
PFE   25.40 (-0.08%)
PYPL   63.11 (-0.24%)
XOM   118.84 (+0.18%)
S&P 500   5,044.20 (+0.44%)
DOW   38,010.74 (+0.68%)
QQQ   426.17 (+0.08%)
AAPL   168.13 (+0.08%)
MSFT   408.42 (-0.83%)
META   507.55 (+2.71%)
GOOGL   156.04 (+0.37%)
AMZN   181.17 (-0.06%)
TSLA   151.16 (-2.76%)
NVDA   846.91 (+0.78%)
AMD   154.87 (+0.55%)
NIO   4.02 (+2.81%)
BABA   69.34 (+0.76%)
T   16.16 (+0.25%)
F   12.11 (+0.58%)
MU   117.10 (+0.66%)
GE   157.73 (+1.32%)
CGC   6.95 (+7.09%)
DIS   113.49 (+0.49%)
AMC   2.81 (-5.70%)
PFE   25.40 (-0.08%)
PYPL   63.11 (-0.24%)
XOM   118.84 (+0.18%)

Arno Therapeutics (ARNI) Short Interest Ratio & Short Volume

Arno Therapeutics Short Interest Data

Current Short Volume
1,500 shares
Previous Short Volume
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$15.00
Short Interest Ratio / Days to Cover
0.0
Last Record Date
July 15, 2021
Today's Trading Volume
0 shares
Average Trading Volume
8,820 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Arno Therapeutics ?

Sign up to receive the latest short interest report for Arno Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARNI Short Interest Over Time

ARNI Days to Cover Over Time

ARNI Percentage of Float Shorted Over Time

Arno Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20211,500 shares $15.00 No ChangeN/A0 $0.01
4/30/20211,000 shares $6.50 +42.9%N/A0.1 $0.01
4/15/2021700 shares $4.55 No ChangeN/A0 $0.01
3/15/2021100 shares $0.44 No ChangeN/A0 $0.00
2/26/2021100 shares $0.42 No ChangeN/A0 $0.00
2/12/2021100 shares $1.15 No ChangeN/A0 $0.01

ARNI Short Interest - Frequently Asked Questions

What is Arno Therapeutics' current short interest?

Short interest is the volume of Arno Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 1,500 shares of ARNI short. Learn More on Arno Therapeutics' current short interest.

Is Arno Therapeutics' short interest increasing or decreasing?

Arno Therapeutics saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,500 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Block, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

What does it mean to sell short Arno Therapeutics stock?

Short selling ARNI is an investing strategy that aims to generate trading profit from Arno Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Arno Therapeutics?

A short squeeze for Arno Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARNI, which in turn drives the price of the stock up even further.

How often is Arno Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARNI, twice per month. The most recent reporting period available is July, 15 2021.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:ARNI) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners